FC gamma RIIa and FC gamma RIIIa single nucleotide polymorphisms (SNPs) and cetuximab benefit in the EXCITE trial

Sclafani, F; Gollins, S; Cunningham, D; Wilson, SH; Kouvelakis, K; Lopes, A; West, N; Quirke, P; Begum, R; Valeri, N; Beare, S; Hughes, L; De Castro, DG; Chau, I

ANNALS OF ONCOLOGY, 2017; 28 ( ):